Yang Jing, Chen An-Er, He Xiao-Bo, Shao Yi-Lian, Wang Qian
Department of Obstetrics and Gynaecology, The Affiliated Women and Children's Hospital of Ningbo University Ningbo 315000, Zhejiang, China.
Am J Transl Res. 2025 Jul 15;17(7):4986-4995. doi: 10.62347/BUUI5663. eCollection 2025.
To investigate the association between thioredoxin-interacting protein (TXNIP), PTEN-induced putative kinase 1 (PINK1) and lipid metabolism in gestational diabetes mellitus (GDM), and to assess their clinical significance.
This case-control study included 220 pregnant women (110 with GDM and 110 healthy controls) recruited from 2022 to 2024. Clinical assessments included glucose, lipids, and thyroid function profiles. TXNIP and PINK1 mRNA expression were measured using RT-qPCR. Pregnancy outcomes were documented using standardized clinical protocols.
Compared to controls, GDM patients had significantly higher fasting blood glucose (FBG), 2-hour postprandial blood glucose (2hPBG), glycated hemoglobin (HbA1c), and homeostasis model assessment of insulin resistance (HOMA-IR), along with reduced fasting insulin (FINS). Thyroid function tests showed elevated triiodothyronine (T3), and thyroxine (T4) levels in the GDM group. Lipid profiles revealed increased triglycerides (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C), and decreased high-density lipoprotein cholesterol (HDL-C). TXNIP expression was significantly elevated, while PINK1 expression was decreased in GDM patients. Correlation analysis indicated strong associations between TXNIP and PINK1 levels with lipid values. GDM was also associated with adverse pregnancy outcomes, including higher rates of cesarean delivery, preterm birth, macrosomia, neonatal hypoglycemia, and lower Apgar scores.
Dyslipidemia in GDM-characterized by elevated TC, TG, and LDL-C and decreased HDL-C-may be associated with upregulation of TXNIP and downregulation of PINK1. These molecular alterations could contribute to metabolic disturbances and poor pregnancy outcomes. Monitoring lipid profiles alongside TXNIP and PINK1 expression may aid in the clinical management of GDM and its complications.
探讨硫氧还蛋白相互作用蛋白(TXNIP)、PTEN诱导的假定激酶1(PINK1)与妊娠期糖尿病(GDM)脂质代谢之间的关联,并评估它们的临床意义。
本病例对照研究纳入了2022年至2024年招募的220名孕妇(110例GDM患者和110例健康对照)。临床评估包括血糖、血脂和甲状腺功能指标。采用RT-qPCR检测TXNIP和PINK1 mRNA表达。使用标准化临床方案记录妊娠结局。
与对照组相比,GDM患者的空腹血糖(FBG)、餐后2小时血糖(2hPBG)、糖化血红蛋白(HbA1c)和胰岛素抵抗稳态模型评估(HOMA-IR)显著升高,同时空腹胰岛素(FINS)降低。甲状腺功能检查显示GDM组三碘甲状腺原氨酸(T3)和甲状腺素(T4)水平升高。血脂谱显示甘油三酯(TG)、总胆固醇(TC)和低密度脂蛋白胆固醇(LDL-C)升高,高密度脂蛋白胆固醇(HDL-C)降低。GDM患者中TXNIP表达显著升高,而PINK1表达降低。相关性分析表明TXNIP和PINK1水平与血脂值之间存在密切关联。GDM还与不良妊娠结局相关,包括剖宫产、早产、巨大儿、新生儿低血糖发生率较高以及阿氏评分较低。
以TC、TG和LDL-C升高以及HDL-C降低为特征的GDM血脂异常可能与TXNIP上调和PINK1下调有关。这些分子改变可能导致代谢紊乱和不良妊娠结局。监测血脂谱以及TXNIP和PINK1表达可能有助于GDM及其并发症的临床管理。